Vitamins and non-alcoholic fatty liver disease: A molecular insight
Volume 5, Issue 2, June 2021, Pages 62-71
Hepatocellular carcinoma recurrence: Predictors and management
Volume 7, Issue 4, December 2023, Pages 321-332
Bile acid receptors and signaling crosstalk in the liver, gut and brain
Volume 5, Issue 3, September 2021, Pages 105-118
Hepatitis B virus as a risk factor for hepatocellular carcinoma: There is still much work to do
Volume 8, Issue 2, June 2024, Pages 83-90
Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena
Volume 6, Issue 2, June 2022, Pages 72-83
Clinical perspectives of isoniazid-induced liver injury
Volume 5, Issue 2, June 2021, Pages 45-52
Metformin alleviates cholestasis-associated nephropathy through regulating oxidative stress and mitochondrial function
Volume 5, Issue 3, September 2021, Pages 171-180
Mitigation of cholestasis-associated hepatic and renal injury by edaravone treatment: Evaluation of its effects on oxidative stress and mitochondrial function
Volume 5, Issue 3, September 2021, Pages 181-193
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease
Volume 5, Issue 3, September 2021, Pages 119-141
Farnesoid X receptor and fibroblast growth factor 15/19 as pharmacological targets
Volume 5, Issue 3, September 2021, Pages 142-150
A fluorescence imaging based-assay to monitor mitophagy in cultured hepatocytes and mouse liver
Volume 5, Issue 1, March 2021, Pages 16-20
Mesenchymal stem cells therapy for acute liver failure: Recent advances and future perspectives
Volume 5, Issue 2, June 2021, Pages 53-61
Iron metabolism in non-alcoholic fatty liver disease: A promising therapeutic target
Volume 6, Issue 4, December 2022, Pages 203-213
Impact of liver enzymes on SARS-CoV-2 infection and the severity of clinical course of COVID-19
Volume 5, Issue 1, March 2021, Pages 21-27
Retinoic acid signaling in fatty liver disease
Volume 7, Issue 3, September 2023, Pages 189-195
Hepatic transcriptome profiling reveals early signatures associated with disease transition from non-alcoholic steatosis to steatohepatitis
Volume 6, Issue 4, December 2022, Pages 238-250
In-depth analysis of de novo lipogenesis in non-alcoholic fatty liver disease: Mechanism and pharmacological interventions
Volume 7, Issue 4, December 2023, Pages 285-295
The clinical implication of gamma-glutamyl transpeptidase in COVID-19
Volume 5, Issue 4, December 2021, Pages 209-216
Novel organoid model in drug screening: Past, present, and future
Volume 5, Issue 2, June 2021, Pages 72-78
Molecular mechanisms of autophagy and implications in liver diseases
Volume 7, Issue 1, March 2023, Pages 56-70
Liver-adipose tissue crosstalk in alcohol-associated liver disease: The role of mTOR
Volume 6, Issue 4, December 2022, Pages 227-237
Microbial transformations of bile acids and their receptors in the regulation of metabolic dysfunction-associated steatotic liver disease
Volume 7, Issue 3, September 2023, Pages 165-176
Radiofrequency ablation of hepatocellular carcinoma: Current status, challenges, and prospects
Volume 7, Issue 2, June 2023, Pages 108-115
Dietary pattern and hepatic lipid metabolism
Volume 7, Issue 4, December 2023, Pages 275-284
Berberine enhances the anti-hepatocellular carcinoma effect of NK92-MI cells through inhibiting IFN-gamma-mediated PD-L1 expression
Volume 6, Issue 3, September 2022, Pages 167-174